Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7967798

Beeline buzzes ahead to pivotal lupus trials after mid-stage success

4+ day, 16+ hour ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7966036

Kura spins out Caspian to take menin inhibitor into diabetes

4+ day, 22+ hour ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7965836

Shionogi's regeneration-inducing drug comes up short in acute ischemic stroke study

5+ day, 57+ min ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7965295

Evommune ends oral drug's dermatitis programme after second mid-stage setback

5+ day, 3+ hour ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7964596

Acting heads of FDA centres land permanent gigs, plus new AI leader

5+ day, 9+ hour ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960381

Next-gen CAR-T from BMS passes pivotal test in quadruple-class exposed myeloma

5+ day, 21+ hour ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960382

Moonwalk unveils gene silencing approach to obesity, $70M in fresh funds

5+ day, 21+ hour ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7957440

Novo's hopes for ziltivekimab dwindle as two heart failure studies stopped early

1+ week, 25+ min ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7957147

FDA OKs withdrawal of colorectal cancer indication for BMS's Krazati

1+ week, 4+ hour ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7952422

Novartis' pelacarsen fails critical cardiovascular test

1+ week, 2+ day ago   (8+ words) FirstWord Pharma...